| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3459 |
| Trial ID | NCT05878184 |
| Disease | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SC291 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) |
| Year | 2023 |
| Country | United States |
| Company sponsor | Sana Biotechnology |
| Other ID(s) | SC291-101 |
| Cohort 1 | |||||||||||
|
|||||||||||